Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-28 02:29:48 - browse：45

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： VC firm General Catalyst wants to buy a health system

WSS

New CMS data security rules will hurt Medicare, Medicaid research

Stroke deaths set to near 10 million globally by 2050

FDA authorizes Novavax’s updated Covid

Obamacare plans could cover weight loss drugs

Medicare Advantage enrollment hits roughly 33.4 million

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

focus

Wikipedia

focus

Alkermes shareholders re

3 questions for the future of Biden's cancer moonshot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Walensky prepares to leave CDC — and Congress — behind

Liquid biopsy for lung cancer is launched by Delfi

Anesthesiologist group: stop taking Ozempic before surgery

AI can decode, harness the power of the humane immune system

Sports medicine is finally prioritizing gender equality

Phenylephrine and the overlooked value of the placebo effect

hotspot

The future of health care in the House

What to expect at HLTH 2023, the health care industry conference

New study raises questions about niacin and heart health

As AI regulations shape up, health tech startups beg for clarity

Was Amgen transparent enough on FDA's concern on cancer drug?

Colorectal cancer study finds potential in overlooked immune cell

explore

focus

leisure time

hotspot